Heparin-Releasable Endothelial Cell-Associated Tissue Factor Pathway Inhibitor (Tfpi) is Increased in the Coronary Circulation After Coronary Spasm in Patients with Coronary Spastic Angina - Evidence for association with and regulation by LDL in human plasma

By Nishiyama K.   Ogawa H.   Yasue H.   Soejima H.   Misumi K.   Kugiyama K.   Tsuji I.   Kumeda K.  

Thrombosis Research, Vol. 89, Iss. 3, 1998-02 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite

Differential Effects of Low Molecular Weight Heparin and Unfractionated Heparin on Circulating Levels of Antithrombin and Tissue Factor Pathway Inhibitor (TFPI) - Insight into its possible mechanism of action

By Hansen J.-B.   Sandset P.M.  

Thrombosis Research, Vol. 91, Iss. 4, 1998-08 ,pp. : 177-181

Elsevier

Access to resources Recommend Favorite

Plasma Tissue Factor Pathway Inhibitor and Tissue Factor Antigen Levels After Administration of Heparin in Patients With Angina Pectoris - Relationship between free and endothelial cell-associated forms of TFPI

By Soejima H.   Ogawa H.   Yasue H.   Nishiyama K.   Kaikita K.   Misumi K.   Takazoe K.   Kugiyama K.   Tsuji I.   Kumeda K.   Nakamura S.  

Thrombosis Research, Vol. 93, Iss. 1, 1999-01 ,pp. : 17-25

Elsevier

Access to resources Recommend Favorite

TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin

By Hoppensteadt D.A.   Walenga J.M.   Fasanella A.   Jeske W.   Fareed J.  

Thrombosis Research, Vol. 77, Iss. 2, 1995-01 ,pp. : 175-185

Elsevier

Access to resources Recommend Favorite

Full-length human tissue factor pathway inhibitor inhibits human activated protein C in the presence of heparin

By Hamamoto T.   Kisiel W.  

Thrombosis Research, Vol. 80, Iss. 4, 1995-11 ,pp. : 291-297

Elsevier

Access to resources Recommend Favorite